Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy

Xolair (omalizumab) - Roche, Novartis

Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy (clinicaltrials.gov) - Sep 30, 2026 - P4 | N=20 | Not yet recruiting | Sponsor: Johns Hopkins University
New P4 trial • Allergy • Food Hypersensitivity • Immunology

http://clinicaltrials.gov/ct2/show/NCT07845552

Sep 30, 2026